Type
Child
Status
Approved
Caption
Title (YouTube)
Caption X
Cover
OG Image
Alt Image Text
Images
Videos
Video Published (Blog)
Publish Date (Social)
Nov 1, 2026 07:30
Scheduled (Social)
Images Posted (Social)
Images Failed (Social)
Videos Posted (Social)
Videos Failed (Social)
Featured
Do not index
Parent item
Videos Post IDs (Social)
Created time
Oct 29, 2026 03:40 PM
Sub-item
Authors
Images Post IDs (Social)
YT Post ID
YT Embedded
Images Delete (Social)
Videos Delete (Social)
A male enhancement supplement sold at certain independently operated GNC franchise stores across the United States has been recalled after testing found undisclosed prescription-drug ingredients. On October 24, 2026, Tonight We Ride, LLC announced a consumer-level recall of all lots of Ultimate Forza Male Supplement capsules after third-party product testing identified undeclared sildenafil, tadalafil, and dapoxetine.
The product was distributed from 2017 through October 1, 2026, through certain independently owned GNC franchise locations, not every GNC store nationwide. According to FOX 35 Orlando, the recall involves all lots of Ultimate Forza Male Supplement capsules, and affected inventory has reportedly been quarantined while sales have stopped.
What Happened
Tonight We Ride, LLC, a company based in Lakeville, Minnesota, said it is recalling Ultimate Forza because the capsules contained sildenafil and tadalafil, the active ingredients in Viagra and Cialis, along with dapoxetine, a drug that is not approved by the FDA in the United States. The FDA’s posted recall notice states that the product contains undeclared Sildenafil, Tadalafil, and Dapoxetine, meaning consumers would not have seen those ingredients on the label.
That matters because supplements are marketed very differently from prescription drugs, and many consumers assume the label tells the whole story. In this recall, the concern is not simply inaccurate labeling. It is the presence of active pharmaceutical ingredients that can interact with other medications and medical conditions in potentially dangerous ways. For readers following our earlier coverage of the FDA recall notice, this latest development keeps the focus on hidden-drug supplement enforcement and consumer risk.
The FDA notice also says the affected products were sold through certain independently operated GNC franchise stores in the United States from 2017 through October 1, 2026. Following the testing, the company said consumers can stop using the product and return it to a GNC store for a full refund under the consumer-level recall instructions.
Why Hidden Drug Ingredients Raise Legal Problems
In general terms, the legal issue starts with how federal law treats dietary supplements versus drugs. A supplement sold without disclosing prescription-level active ingredients can draw scrutiny under the Federal Food, Drug, and Cosmetic Act because the product may be considered adulterated, misbranded, or even an unapproved drug depending on the facts.
The FDA has repeatedly warned about sexual enhancement products tainted with undisclosed pharmaceuticals, and its health fraud product database tracks recalls and public notifications involving products marketed with hidden drug ingredients. Here, the risk is especially significant because sildenafil and tadalafil are phosphodiesterase-5 inhibitors that can lower blood pressure and interact with nitrate medications commonly used by people with diabetes, high blood pressure, high cholesterol, or heart disease, according to the FDA’s safety explanation in the recall notice.
That can create several layers of legal exposure. Manufacturers may face regulatory action tied to product composition and labeling. Retail channels may face questions about sourcing, vendor oversight, and consumer communications. And if a consumer experienced a medical event after taking the product, attorneys evaluating the facts might look at potential product liability, failure-to-warn, negligence, breach-of-warranty, or consumer protection issues depending on the state and the evidence available.
Why The Franchise Detail Matters
One notable detail in this recall is the distribution channel. The FDA says the supplement was sold at certain independently operated franchise locations, which may become important in any later dispute over responsibility, notice, or returns. Franchise structures can complicate questions about who selected the product, who controlled store-level sales, and who had authority over quality assurance practices.
That does not automatically answer who may be legally responsible in any individual case. But it often affects how claims are investigated. Some people in similar situations find that the facts surrounding distribution agreements, testing procedures, indemnity provisions, insurance coverage, and recall communications become central very quickly.
It also matters that GNC reportedly commissioned the testing that uncovered the undeclared ingredients. FOX 35 Orlando reported that third-party testing conducted for GNC identified the undeclared ingredients, after which the stock was quarantined and sales stopped. From a legal perspective, that sequence may become part of any timeline showing when different parties learned of the issue and what steps followed.
What Consumers And Businesses May Be Watching Next
For consumers, the immediate concern is health and documentation. People who bought Ultimate Forza may be paying attention to lot information, receipts, packaging, purchase dates, and any symptoms or medical treatment that followed use of the product. In matters involving recalled supplements, those details often become important later, especially if the timeline stretches back several years as it does here.
For retailers and distributors, the next phase often involves internal review. That can include vendor onboarding records, testing data, inventory tracking, consumer refund procedures, and recall notice dissemination. In a recall involving hidden drugs, businesses may also be watching for adverse-event reports, regulatory follow-up, and possible civil claims.
For manufacturers, recalls like this can trigger more than one type of exposure at once: FDA scrutiny, private litigation, reputational damage, and commercial disputes between sellers and suppliers. Where a product remained in commerce from 2017 through October 1, 2026, attorneys often examine what was known, when it was known, and whether existing compliance systems were designed to detect problems sooner.
What This May Mean For Affected Parties
If a consumer became ill after taking a recalled supplement, an attorney might help determine whether the facts support a claim tied to injury, medical costs, or misleading product labeling. If a store sold affected inventory, counsel may be useful in sorting out refund obligations, insurance issues, supplier communications, and document preservation. If a company participated in the supply chain, legal review may focus on contracts, testing records, and regulatory reporting.
In general terms, recall cases involving undeclared pharmaceuticals can become more serious than routine labeling disputes because they raise questions about both safety and product identity. Here, the core allegation is not that the supplement was merely ineffective. It is that the product allegedly contained active drug ingredients consumers were not told about.
That distinction often changes how injured consumers, retailers, and manufacturers evaluate risk. It may also shape whether a case centers on consumer fraud theories, product defect theories, personal injury allegations, or some combination of all three. As this story develops beyond our prior report on the supplement recall, affected parties may be looking closely at how the recall is administered and whether any additional regulatory findings emerge.
If you're facing legal challenges, ReferU.AI analyzes billions of court records to match you with attorneys who've successfully represented cases just like yours.
